As an alternative cell survival pathway, STAT5a/b has a pro-tumor effect, via overexpression and activation, in head and neck squamous cell carcinomas [35], and EGFR has been shown to activate STAT5a/b in breast cancer cell lines [36–38]. This evidence concerns the gene STAT5A and breast cancer.